Shots:
- Pixee Medical has received CE mark for Knee+ NexSight, its AR-based total knee arthroplasty solution, with initial procedures completed in EU & a 510(k) submission under FDA review
- Knee+ NexSight projects a virtual display with voice control during knee arthroplasty, without the need for a robot, console, or disposables, while delivering robotic-level accuracy with less invasive tools, reduced blood loss, & seamless workflow integration
- Knee+ NexSight supports most primary knee implants & personalized alignment, incl. kinematic alignment, with its software architecture allowing secure third-party integration & remote updates for increasingly data-driven operating rooms
Ref: Pixee Medical | Image: Pixee Medical | Press Release
Related News: LivaNova’s aura6000 System Secures the US FDA Premarket Approval to Treat Obstructive Sleep Apnea (OSA)
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
